Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer

Journal of Cancer Science and Therapy

Volumn 3, Issue 6, 2011, Pages 120-124

  Wampfler, Jason A ^a   Aubry, Marie Christine ^a   Yang, Ping ^a   Riehle, Darren L ^a   Dilara Savci Heijink, C ^a   Mandrekar, Sumithra ^a   Lingle, Wilma L ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

F 1; Immunohistochemistry tt; Ki 67; Lung cancer; P53; Tissue microarrays

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1;

ADULT; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; SYSTEMATIC ERROR; TISSUE MICROARRAY;

EID: 84857075127     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000072     Document Type: Article

References (20)

1. Horvath L and Henshall S (2001) The application of tissue microarrays to cancer research. Pathology 33: 125-129.
2. Fons G, van der Velden J, Burger M, Ten Kate F (2009) Validation of tissue microarray technology in vulvar cancer. Int J Gynecol Pathol 28: 76-82.
3. Rubin MA, Dunn R, Strawderman M, Pienta KJ (2002) Tissue microarray sampling strategy for prostate cancer biomarker analysis. American Journal of Surgical Pathology 26: 312-319.
4. Hecht JL, Kotsopoulos J, Gates MA, Hankinson SE, Tworoger SS (2008) Validation of tissue microarray technology in ovarian cancer: results from the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 17: 3043-3050.
5. Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, et al. (2004) Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol 17: 790-797.
6. Simon R, Mirlacher M and Sauter G (2004) Tissue microarrays. Biotechniques 36: 98-105.
7. Kallioniemi OP, Wagner U, Kononen J, Sauter G (2001) Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics 10: 657-662.
8. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
9. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, et al. (2001) Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158: 1245-1251.
10. Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80: 1943-1949.
11. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, et al. (2004) Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in nonsmall cell lung cancer. Clin Cancer Res 10: 4314-4324.
12. Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, et al. (2007) Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol 38: 276-283.
13. Hoos A, Cordon-Cardo C (2001) Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 81: 1331-1338.
14. Skacel M, Skilton B, Pettay JD and Tubbs RR (2002) Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data. Appl Immunohistochem Mol Morphol 10: 1-6.
15. Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, et al. (1985) Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 16: 569-579.
16. Macdonald C, Michael A, Colston K, Mansi J (2004) Heterogeneity of immunostaining for tumour markers in non-small cell lung carcinoma. Eur J Cancer 40: 461-466.
17. Schmidt LH, Biesterfeld S, Kummel A, Faldum A, Sebastian M, et al. (2009) Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue. Anticancer Res 29: 201-209.
18. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, et al. (2005) Clinical Features of 5,628 Primary Lung Cancer Patients: Experience at Mayo Clinic from 1997-2003. Chest 128: 452-462.
19. Yatabe Y, Mitsudomi T, Takahashi T (2002) TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 26: 767-773.
20. Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, et al. (2010) Tissue microarrays: one size does not fit all. Diagn Pathol 5: 48.